Blue Lake Biotechnology, Inc. — Form D/A
Blue Lake Biotechnology, Inc. of ATHENS, GA, a company, filed a Form D amendment with the SEC on 2020-11-06. The offering totals $8.8M, of which $8.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-11-06
- Form: D/A
- Accession: 0001802857-20-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $8.8M
- Amount sold: $8.8M
- Investors: 1
- Date of first sale: 2019-12-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-361848
Issuer
- Name: Blue Lake Biotechnology, Inc.
- CIK: 0001802857
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 111 RIVERBEND ROAD, ATHENS, GA, 30602
- Phone: 706-201-8820
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Jixiang An | Director | Athens, GA |
| Biao He | Director | San Francisco, CA |
| Biao He | Executive Officer | San Francisco, CA |
| Biao He | Promoter | San Francisco, CA |
| Yuan Lin | Director | Athens, GA |
| Fred Quinn | Director | Athens, GA |
| Ji Ma | Director | Athens, GA |
Other filings by this issuer (2)
More